#TranspireBio

Last 24h 📊 Neutral 📊1

Last 7 Days 📊 Neutral 📊1

Last 30 Days 📊 Neutral 📊1

Release 📈 Stocks — 📊 Neutral

TranspireBio Completes Phase 1 Pharmacokinetic Study for Inhaled Therapeutics

October 6, 2026 (47 minutes ago)

TranspireBio Holdings Inc. advances its respiratory drug pipeline after successfully completing a pivotal Phase 1 pharmacokinetic study for its lead inhaled therapeutic…

🌍 AMERICAS Read More →